AI Image
FDA-Approval for Drill-Free Cavity Care May Be Imminent After Great Phase 3 Treatment Trial
Good News Network • • health
Key Points:
- The FDA is close to approving silver diamine fluoride (SDF), a simple liquid treatment that arrests tooth decay without drilling, shots, or sedation, potentially sparing thousands of children from painful dental procedures.
- A University of Michigan-led Phase III clinical trial involving 830 children under age 6 demonstrated that SDF effectively halted decay in over half of treated baby teeth when applied every six months.
- SDF has been used off-label in the US since 2014 for tooth sensitivity but lacked large-scale clinical trial data for FDA approval as a cavity treatment until now.
- The treatment is especially beneficial for young children, older adults, and patients who cannot tolerate conventional dental care, though it permanently darkens decayed areas of teeth.
- FDA approval would likely increase SDF usage, improve insurance coverage, and ensure consistent product quality, offering a safe, effective, and inexpensive alternative to traditional cavity treatments.
